Clindamycin Phosphate for Injection

Clindamycin Phosphate for Injection (CAS 24729-96-2) is a chemically synthesized prodrug with no antibacterial activity on its own that is rapidly hydrolyzed in the body into active clindamycin. Manufactured directly by Cisen Pharmaceutical Co., Ltd. to USP standards in 0.3g, 0.6g, and 0.9g specifications, it is clinically used to treat infections caused by gram-positive and anaerobic bacteria. Samples are available, and the product is sold across North America, Central/South America, Western and Eastern Europe, Australasia, Asia, the Middle East, and Africa.